+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Capsule Endoscopy Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 147 Pages
  • April 2023
  • Region: Global
  • Expert Market Research
  • ID: 5798017
The global capsule endoscopy market size attained a value of USD 882.8 million in 2022. The market is anticipated to grow at a CAGR of 8.7% during the forecast period of 2023-2031 to attain a value of USD 1870.3 million by 2031.

Capsule Endoscopy Market: Introduction

Capsule endoscopy is a non-invasive, diagnostic procedure that allows a doctor to examine the lining of the middle part of the gastrointestinal tract, which includes the three portions of the small intestine (duodenum, jejunum, and ileum).

The procedure involves the patient swallowing a small capsule, about the size of a large vitamin pill, which contains a tiny wireless camera. As the capsule travels through the gastrointestinal tract, it takes thousands of pictures that are transmitted to a recorder the patient wears on a belt around their waist. The images can then be downloaded onto a computer, where the doctor can view them. The capsule is eventually expelled naturally from the body in the stool.

Capsule endoscopy is primarily used to visualize parts of the gastrointestinal tract that cannot be seen with other types of endoscopies such as colonoscopy or esophagogastroduodenoscopy. It is often used to help diagnose conditions such as Crohn's disease, celiac disease, or gastrointestinal bleeding of unknown origin. It can also be used to examine the oesophagus or colon, though this is less common.

The benefits of capsule endoscopy include:

  • Non-Invasive: As the procedure does not involve anaesthesia or sedation, it is less invasive than traditional endoscopy. There is also no risk of perforation or bleeding
  • Comprehensive: It allows for a detailed examination of the small intestine, an area that is difficult to visualize with traditional endoscopy procedures
  • Comfortable: As the capsule is simply swallowed like a pill, most patients find the procedure comfortable
  • Functional: It allows for visualization of the gastrointestinal tract in its functioning state, which can provide valuable information about motility disorders
Despite these benefits, it is important to note that capsule endoscopy does have some limitations. For instance, it does not allow for therapeutic interventions - such as biopsies or polyp removal - that can be done with traditional endoscopy procedures. Also, certain conditions, like intestinal narrowing, may prevent the use of capsule endoscopy.

Capsule Endoscopy Market Segmentations

The market can be categorised into product type, application, end user, and region.

Capsule Endoscopy Market Breakup by Product type

  • Capsule Endoscopes
1. Small Bowel
2. Esophageal
3. Colon
  • Systems

Capsule Endoscopy Market Breakup by Application

  • OGIB (obscure GI tract bleeding)
  • Crohn’s Disease
  • Small Intestine Tumor
  • Others

Capsule Endoscopy Market Breakup by End user

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Capsule Endoscopy Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Capsule Endoscopy Market Scenario

The global capsule endoscopy market continues to grow, fuelled by a rise in the prevalence of gastrointestinal diseases, an aging global population, and technological advancements in capsule endoscopy systems.

In terms of prevalence, the increasing occurrence of conditions such as Crohn's disease, colorectal cancer, and peptic ulcers, among others, drives the demand for capsule endoscopy. This procedure provides a minimally invasive, comprehensive method for visualizing the entirety of the small intestine and detecting these diseases.

The aging population worldwide is another significant factor contributing to the market's expansion. As age is a major risk factor for many gastrointestinal diseases, the demand for capsule endoscopy is expected to rise with an increase in the elderly population.

Technological advancements have also played a vital role in propelling the market. Modern capsule endoscopy systems have evolved significantly, offering improved imaging capabilities, longer battery life, and greater patient comfort. The development of capsules with adjustable frame rates and view angles, as well as those that can transmit real-time images, are some of the innovations that are encouraging the adoption of this technology.

Furthermore, the preference for non-invasive procedures over conventional endoscopy methods boosts the growth of the capsule endoscopy market. The convenience and comfort associated with swallowing a capsule, as opposed to the invasiveness of traditional endoscopy, make it an attractive option for both doctors and patients.

Geographically, North America and Europe hold significant shares of the market due to the presence of advanced healthcare infrastructure, increased awareness, and higher healthcare expenditure. However, the Asia-Pacific region is expected to witness rapid growth due to the large patient population, rising incidence of gastrointestinal diseases, and improving healthcare facilities.

However, there are challenges facing the market. The high cost of capsule endoscopy systems and the fact that capsule endoscopy cannot perform therapeutic interventions like biopsies or polyp removals are some factors that may limit market growth.

Overall, the capsule endoscopy market is poised for substantial growth due to the rising demand for non-invasive diagnostic procedures, the increasing prevalence of gastrointestinal diseases, and continuous technological advancements in the field.

Key Players in the Global Capsule Endoscopy Market

The report gives an in-depth analysis of the key players involved in the capsule endoscopy market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
  • Boston Scientific Corporation
  • CapsoCam Plus
  • ConMed Corporation
  • Cook
  • The Guidant Group
  • INTROMEDIC
  • JINSHAN Science & Technology
  • Medtronic
  • Olympus Corporation
  • RF Co.,Ltd
  • Fujifilm Holdings Corporation
  • Check-Cap
  • Accu-Read, INC.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Capsule Endoscopy Market Overview
3.1 Global Capsule Endoscopy Market Historical Value (2016-2022)
3.2 Global Capsule Endoscopy Market Forecast Value (2023-2031)
4 Global Capsule Endoscopy Market Landscape
4.1 Global Capsule Endoscopy Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Capsule Endoscopy Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Applications
4.2.3 Analysis by End Users
5 Global Capsule Endoscopy Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Capsule Endoscopy Market Segmentation
6.1 Global Capsule Endoscopy Market by Product Type
6.1.1 Market Overview
6.1.2 Capsule Endoscopes
6.1.2.1 Small Bowel
6.1.2.2 Esophageal
6.1.2.3 Colon
6.1.3 Systems
6.2 Global Capsule Endoscopy Market by Applications
6.2.1 Market Overview
6.2.2 OGIB (obscure GI tract bleeding)
6.2.3 Crohn’s Disease
6.2.4 Small Intestine Tumor
6.2.5 Others
6.3 Global Capsule Endoscopy Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Ambulatory Surgical Centers
6.3.4 Others
6.4 Global Capsule Endoscopy Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Capsule Endoscopy Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Capsule Endoscopy Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Capsule Endoscopy Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Capsule Endoscopy Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Capsule Endoscopy Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Boston Scientific Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 CapsoCam Plus
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 ConMed Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Cook
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 The Guidant Group
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 INTROMEDIC
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 JINSHAN Science & Technology
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Medtronic
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Olympus Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 RF Co.,Ltd.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Fujifilm Holdings Corporation
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Check-Cap.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Accu-Read, INC.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Capsule Endoscopy Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Boston Scientific Corporation
  • Capsocam Plus
  • Conmed Corporation
  • Cook
  • The Guidant Group
  • Intromedic
  • Jinshan Science & Technology
  • Medtronic
  • Olympus Corporation
  • Rf Co. Ltd.
  • Fujifilm Holdings Corporation
  • Check-Cap.
  • Accu-Read, Inc.

Methodology

Loading
LOADING...

Table Information